Search Results

[EFFECTIVE data. New effectiveness dimensions in antihypertensive combination therapy].

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2011 Jan 27; Vol. 153 (4), pp. 50.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Focus on compliance. Rapid goal attainment in hypertension].

• Authors : Riem L

Subjects: Medication Adherence*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2011 Jan 27; Vol. 153 (4), pp. 51.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

Two- and three-drug therapy with candesartan cilexetil (Atacand) successful in patients with severe hypertension.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*administration & dosage ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*administration & dosage

• Source: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners [Cardiovasc J S Afr] 2005 Sep-Oct; Vol. Publisher: Published for Clinics-Cardive Pub. Co. by MASA Multimedia Country of Publication: South Africa NLM ID: 100964061 Publication Model: Print Cited

Record details

CHARM study in CHF patients with impaired LV function reinforces benefits of candesartan cilexetil (Atacand).

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

• Source: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners [Cardiovasc J S Afr] 2004 Sep-Oct; Vol. Publisher: Published for Clinics-Cardive Pub. Co. by MASA Multimedia Country of Publication: South Africa NLM ID: 100964061 Publication Model: Print Cited

Record details

CHARM shows improvement in NYHA functional class with candesartan.

Subjects: Tetrazoles*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

• Source: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners [Cardiovasc J S Afr] 2004 Mar-Apr; Vol. Publisher: Published for Clinics-Cardive Pub. Co. by MASA Multimedia Country of Publication: South Africa NLM ID: 100964061 Publication Model: Print Cited

Record details

The CHARM programme raises the profile of candesartan cilexetil in the treatment of chronic health failure.

Subjects: Angiotensin II Type 1 Receptor Blockers*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

• Source: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners [Cardiovasc J S Afr] 2004 Jan-Feb; Vol. Publisher: Published for Clinics-Cardive Pub. Co. by MASA Multimedia Country of Publication: South Africa NLM ID: 100964061 Publication Model: Print Cited

Record details

CHARM shows benefits of Atacand for symptomatic heart failure.

Subjects: Angiotensin Receptor Antagonists* ; Tetrazoles*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

• Source: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners [Cardiovasc J S Afr] 2003 Sep-Oct; Vol. Publisher: Published for Clinics-Cardive Pub. Co. by MASA Multimedia Country of Publication: South Africa NLM ID: 100964061 Publication Model: Print Cited

Record details

Outcomes data for Atacand: results of the SCOPE study.

Subjects: Tetrazoles*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*administration & dosage

• Source: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners [Cardiovasc J S Afr] 2003 May-Jun; Vol. Publisher: Published for Clinics-Cardive Pub. Co. by MASA Multimedia Country of Publication: South Africa NLM ID: 100964061 Publication Model: Print Cited

Record details